NICA Submits Response to Step Therapy in Medicare Advantage Plans


January 29, 2019

The National Infusion Center Association submitted its formal comments to CMS in response to the administration allowing Medicare Advantage (MA) plans to utilize step therapy strategies for Part B drugs.

NICA Submits Comments on IPI Model


January 3, 2019

The National Infusion Center Association Submitted its formal comments to CMS in response to the administration’s advance notice of proposed rulemaking.

NICA Submits Petition to UnitedHealthcare on Downcoding


October 26, 2018

The National Infusion Center Association and the National Organization of Rheumatology Managers fight the downcoding of biologic drugs

Welcome New NICA Provider Members!


August 31, 2018

We would like to welcome and thank the following infusion provider members who recently joined NICA!

NICA Online Resource Center is Live


July 26, 2018

The new NICA resource center is now live, with tools such as sponsored listings, late-stage pipeline reports, and center reports to help infusion providers better connect and care for their patients.

NICA Submits Comments to HHS Secretary Alex Azar on Blueprint to Lower Drug Prices


July 18, 2018

On Monday, the National Infusion Center Association (NICA) submitted formal comments to the U.S. Department of Health and Human Services (HHS) Secretary Alex Azar in response to the agency’s request for information on the American Patients First blueprint to lower drug prices.

Soccer Stars with Goals to Raise Awareness for Chronic Autoimmune Diseases


July 16, 2018

These world-class soccer champions’ careers were impacted by autoimmune diseases and have dedicated their platforms to raise awareness for those with a similar diagnosis.

National Infusion Center Association to Host Inaugural Conference in Austin, TX


July 11, 2018

NICA will host its first conference July 21-22, 2019 at the JW Marriott in downtown Austin, TX.

NICA Calls for Fixes to the 340B Drug Discount Program


June 27, 2018

NICA and 57 other patient groups, health care organizations, and advocates sign letter to HHS Secretary calling for fixes to the 340B program.

What USP <797> and New Hampshire Senate Bill 581 Means for Infusion Providers


June 25, 2018

New Hampshire Senate Bill 581 was signed by state governor Chris Sununu on June 12, amending the state’s definition of compounding. Read more about how NICA partnered with other concerned stakeholders to protect the in-office infusion delivery channel in New Hampshire.

A Win-Win Weekend at McKesson’s  Onmark Rheumatology Summit


June 22, 2018

In support of NICA’s mission to serve in-office infusion practices, McKesson announced a $3,200 donation to NICA, $100 in honor of each of the 32 practices in attendance at McKesson’s Onmark Rheumatology Summit, which took place June 14-16 in San Antonio, TX.


Thank you for your interest in NICA. We are eager to connect with you and to discuss the exciting work of increasing patient access to infusible and injectable therapies.

If you have questions or concerns, please send us an email and a member of our team will contact you shortly.


Log in with your credentials


Forgot your details?

Create Account